Related Experiment Videos
Somatostatin analogues and multiple receptors: possible physiological roles
1Department of Medicine, Tulane University Medical Center, New Orleans, LA 70112, USA.
Ciba Foundation Symposium
|January 1, 1995
Summary
Researchers developed specific somatostatin receptor ligands to study physiological roles. These novel analogues show promise for therapeutic advantages over existing treatments.
Area of Science:
- Endocrinology and Pharmacology
- Molecular Biology
- Medicinal Chemistry
Background:
- Five somatostatin receptors (sstr1-5) are crucial for various physiological processes.
- Synthetic analogues are needed to selectively target specific somatostatin receptors.
- Understanding receptor-ligand interactions is key to developing targeted therapies.
Purpose of the Study:
- To screen synthetic somatostatin analogues for binding affinities to cloned somatostatin receptors.
- To develop receptor-specific ligands for sstr2, sstr3, and sstr5.
- To elucidate the physiological roles of individual somatostatin receptors.
Main Methods:
- Transfected cell lines expressing cloned somatostatin receptors were utilized.
- Extensive families of synthetic analogues, including cyclic octapeptides and linear peptides, were screened.
- Binding affinities of analogues to sstr1-5 were determined.
Main Results:
- Octreotide analogues showed high affinity for sstr2.
- Linear peptides demonstrated selectivity for sstr3 and/or sstr5.
- Developed a panel of specific ligands for sstr2, sstr3, and sstr5.
Conclusions:
- Receptor-specific ligands are valuable tools for studying somatostatin receptor functions.
- Inhibition of growth hormone and glucagon release is sstr2 mediated.
- Somatostatin effects on insulin, amylase, and gastric acid secretion are linked to sstr5 and sstr2 affinities, respectively.